glp 1 addiction study A new found that people taking GLP-1 drugs had lower rates of substance use disorders — including alcohol, nicotine, cannabis, cocaine, and opioids IUPHAR review – Glucagon-like peptide-1
Description
New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- Zealthy today announced an expansion of its insurance-coordination program for eligible patients...

Click here to read more.

Here's a link if you are interested in participating in the study: longcovid.scripps.edu/locitt-t

I am pleased to share our latest study, now published in Annals of Internal Medicine

Take 1 capsule before your meal to experience digestive delight.

Learn the difference between FDA-approved GLP-1 medications and unapproved research peptides, plus
